ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

NMC Nmc Health Plc

938.40
0.00 (0.00%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Nmc Health Plc LSE:NMC London Ordinary Share GB00B7FC0762 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 938.40 940.00 941.60 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

NMC Health Plc Notice of Full Year Results (6428Q)

20/02/2019 1:43pm

UK Regulatory


Nmc Health (LSE:NMC)
Historical Stock Chart


From Mar 2019 to Mar 2024

Click Here for more Nmc Health Charts.

TIDMNMC

RNS Number : 6428Q

NMC Health Plc

20 February 2019

20 February 2019

NMC Health plc

(the "Company" or "NMC")

Notice of Full Year Results on 7 March 2019

NMC Health plc (LSE: NMC), the leading private healthcare operator in the Gulf Cooperation Council (GCC) with international services across 18 countries, will report its full year financial results (for the 12 months to 31 December 2018) on Thursday, 7 March 2019.

The results are expected to be published on the Regulatory News Service of the London Stock Exchange at 7am GMT on 7 March 2019 and shortly thereafter on the Company's website at https://nmc.ae/investor-relations.

Contacts

 
 NMC 
 Prasanth Manghat, Chief Executive 
  Officer 
  Prashanth Shenoy, Chief Financial          +971 (0)50 522 5648 
  Officer                                     +971 (0)56 329 0545 
  Asjad Yahya, Investor Relations             +971 (0)56 219 0975 
 
 Media 
 FTI Consulting, London 
 Brett Pollard / Victoria Foster Mitchell    +44 (0)20 3727 1000 
 
 FTI Consulting, Gulf 
 Shane Dolan                                 +971 (0)4 437 2100 
 

About NMC Health

NMC the leading private healthcare operator in the GCC with an international network of hospitals across 18 countries. NMC also ranks as one of the top three in-vitro fertilisation ("IVF") operators globally. The Group is also a leading provider of long-term medical care in the UAE through its subsidiary ProVita. Pursing an aggressive international expansion program from 2016, the company now has over 34% of its licensed bed capacity in the Kingdom of Saudi Arabia (KSA), where the company has introduced long-term and multi-specialty care services. Moreover, the recent formation of a joint venture with GOSI/Hassana Investment Company is set to substantially boost the Group's bed capacity in KSA, with the JV expected to be the second largest healthcare operator in the Kingdom in terms of number of beds. NMC received over 5.7m patients in 2017. The Group is also a leading UAE supplier of products and consumables across several key market segments, with the major contribution coming from healthcare related products. The Group reported revenues of US$1.6 billion for the year ended 31 December 2017.

In April 2012 NMC was listed on the Premium Segment of the London Stock Exchange. NMC is a constituent of the FTSE 100 Index.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

NORURSORKAAUUAR

(END) Dow Jones Newswires

February 20, 2019 08:43 ET (13:43 GMT)

1 Year Nmc Health Chart

1 Year Nmc Health Chart

1 Month Nmc Health Chart

1 Month Nmc Health Chart

Your Recent History

Delayed Upgrade Clock